Multicomponent Intervention Study- Blood Donors With High Cholesterol
Recruiting now · Not applicable
Conditions studied: Lipid Metabolism Disorder
In brief
The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).
Key facts
- Study ID
- NCT05693701
- Run by
- University of Texas Southwestern Medical Center
- People needed
- 100
- Starts
- 2023-02-27
- Expected to finish
- 2027-04-30
- Last updated by the study team
- 2026-03-17
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria
- Age 18 to 75 years
You may not qualify if…
- Currently taking medication to lower cholesterol
- Taking any medication that can interact with statins
- Pregnancy
- Identified secondary cause of elevated lipids
- Chronic liver disease or significantly elevated liver function tests (> 3 times upper limit)
Where it is running
- UT Southwestern Medical Center — Dallas, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.